Cost of illness and drivers of cost in atrial fibrillation in Sweden and Germany

Applied Health Economics and Health Policy

Volumn 8, Issue 5, 2010, Pages 317-325

  Jönsson, Linus ^a   Eliasson, Åsa ^b   Kindblom, John ^b   Almgren, Olle ^b   Edvardsson, Nils ^b,c  

^a i3 Innovus ^*  (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atrial fibrillation; Cost of illness

Indexed keywords

ADULT; AGED; ARTICLE; ASTHMA; CEREBROVASCULAR DISEASE; CLINICAL PRACTICE; COMORBIDITY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; EMPLOYMENT STATUS; FEMALE; GERMANY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTPATIENT DEPARTMENT; PHYSICIAN; PRIMARY MEDICAL CARE; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; SWEDEN;

EID: 77956269450     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.2165/11319880-000000000-00000     Document Type: Article

References (21)

1. Boriani G, Diemberger I, Martignani C, et al. The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systems. Eur Heart J 2006; 27 (8): 893-894
2. Le Heuzey JY, Paziaud O, Piot O, et al. Cost of care distribution in atrial fibrillation patients: the COCAF study. Am Heart J 2004; 147 (1): 121-126
3. Stewart S, Murphy NF, Walker A, et al. Cost ofan emergingepidemic: an economic analysis of atrial fibrillation in the UK. Heart 2004; 90 (3): 286-292
4. Wu EQ, Birnbaum HG, Mareva M, et al. Economic burdenand co-morbidities of atrial fibrillation in a privately insured population. CurrMed Res Opin 2005; 21 (10): 1693-1699
5. Statistical yearbook of Sweden: salaries and wages 2004.Orebro: Statistics Sweden, 2004
6. Statistisches Bundesamt Deutschland [online]. Available fromURL: http://www.destatis.de/presse/deutsch/pm2005/p301 0042.htm [Accessed 2010 Aug 20]
7. Efron B, Tibshirani RJ. An introduction to the bootstrap.Boca Raton (FL): Chapman & Hall, 1993
8. Bruggenjurgen B, Rossnagel K, Roll S, et al. The impact of atrial fibrillation on the cost of stroke: the berlin acute stroke study. Value Health 2007; 10 (2): 137-143
9. Nixon RM, Thompson SG. Parametric modelling of cost data in medical studies. Stat Med 2004; 23 (8): 1311-31
10. Marshall DA, Levy AR, Vidaillet H, et al. Cost-effectiveness of rhythm versus rate control in atrial fibrillation. Ann Intern Med 2004 Nov 2; 141 (9): 653-661
11. Hagens VE, Vermeulen KM, TenVergert EM, et al. Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation: results from the RAte Control versus Electrical cardioversion (RACE) study. Eur Heart J 2004 Sep; 25 (17): 1542-1549
12. Pietrasik A, Kosior DA, Niewada M, et al. The cost comparison of rhythm and rate control strategies in persistent atrial fibrillation. Int J Cardiol 2007 May 16; 118 (1): 21-27
13. Caro JJ. An economic model of stroke in atrial fibrillation: the cost of suboptimal oral anticoagulation. Am J Manag Care 2004 Dec; 10 (14 Suppl.): S451-61
14. Reynolds MR, Essebag V, Zimetbaum P, et al. Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry. J Car- diovasc Electrophysiol 2007; 18 (6): 628-633
15. KannelWB, WolfPA, BenjaminEJ, etal. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82 (8A): 2-9N
16. Flegel KM, Shipley MJ, Rose G. Risk of stroke in non-rheumatic atrial fibrillation. Lancet 1987; 1 (8532): 526-529
17. Furberg CD, Psaty BM, Manolio TA, et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994; 74 (3): 236-241
18. Wolf PA, Benjamin EJ, Belanger AJ, et al. Secular trends in the prevalence of atrial fibrillation: the Framingham Study. Am Heart J 1996; 131 (4): 790-795
19. Kannel WB, Abbott RD, Savage DD, et al. Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J 1983; 106 (2): 389-396
20. Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006; 27 (8): 949-953
21. Jonsson B, Haglund U. Economic burden of NSAID-induced gastropathy in Sweden. Scand J Gastroenterol 2001; 36 (7): 775-779